Adcetris FDA approval expanded to include later-stage Hodgkin's
(HealthDay)—U.S. Food and Drug Administration approval of Adcetris (brentuximab vedotin) has been expanded to include adults with untreated stage III or IV classical Hodgkin's lymphoma, the agency
Updated on: March 30,2024
19

Adcetris FDA approval expanded to include later-stage Hodgkin's
(HealthDay)—U.S. Food and Drug Administration approval of Adcetris (brentuximab vedotin) has been expanded to include adults with untreated stage III or IV classical Hodgkin's lymphoma, the agency
Updated on:March 30,2024
19
